Dataset Information


Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.

ABSTRACT: BACKGROUND:Both the 7th and 8th editions of the American Joint Committee on Cancer (AJCC) staging system for perihilar cholangiocarcinoma (pCCA) had the same definition for T2a and T2b. But the value of this classification as prognostic factor remains unclear. METHODS:178 patients with stage T2a or T2b who underwent curative intent resection for pCCA between Jan 2010 and Dec 2018 were enrolled. Relationships between survival and clinicopathological factors including patient demographics and tumor characteristics were evaluated using univariate and multivariate Cox regression analysis. The overall survival (OS) were calculated by Kaplan-Meier method. RESULTS:There was no significant difference in OS between T2a and T2b groups, and the median OS duration were 37 and 31?months (P =?0.354). Both the 7th and 8th edition of the AJCC TNM staging demonstrated a poor prognostic predictive performance. High level of preoperative AST (?85.0?IU/L) and CA19-9 (?1000?U/mL), vascular resection and lower pathological differentiation of the tumor were the independent predictors for poor survival after resection. CONCLUSION:The newly released 8th edition of AJCC staging system demonstrated a poor ability to discriminate the prognosis of patients with stage T2a and T2b pCCA after resection.


PROVIDER: S-EPMC7650292 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7577811 | BioStudies
2019-01-01 | S-EPMC6639239 | BioStudies
1000-01-01 | S-EPMC6354565 | BioStudies
2017-01-01 | S-EPMC5683565 | BioStudies
| S-EPMC5611666 | BioStudies
2020-01-01 | S-EPMC6588495 | BioStudies
2020-01-01 | S-EPMC7043951 | BioStudies
2019-01-01 | S-EPMC6487090 | BioStudies
2020-01-01 | S-EPMC7668515 | BioStudies
2020-01-01 | S-EPMC7059325 | BioStudies